Remedy Entertainment

14.14 EUR

+0.14 %

11,431 following

REMEDY

NASDAQ Helsinki

Software

Technology

+0.14 %
+15.90 %
-2.48 %
-6.97 %
+4.28 %
-19.66 %
-43.33 %
-69.13 %
+111.36 %

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Read more
Market cap
192.88M EUR
Turnover
89.58K EUR
P/E (adj.) (26e)
72.17
EV/EBIT (adj.) (26e)
41.68
P/B (26e)
3.27
EV/S (26e)
1.4
Dividend yield-% (26e)
-
Coverage
Recommendation
Buy
Target price
19.00 EUR
Updated
05.05.2026
Disclaimer
Atte Riikola
Atte Riikola

Analyst

Latest research

Latest analysis report

Released: 06.05.2026

Latest extensive report

Released: 18.12.2024

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
11.8
2026

Interim report Q2'26

3.11
2026

Business review Q3'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
900k wishlists on Steam reached. If this is even close to being accurate, it provides an excellent starting point for the preorder/release date announcement. Source: Gamalytic
yesterday
33
Inspired by T2’s earnings report, here is some reflection/speculation regarding M&A opportunities in the post-Resonant era. While reading the transcript of Take-Two’s earnings call, I came across some interesting comments. In his remarks before the Q&A, Zelnick hints that T2 is in...
5/22/2026, 10:10 AM
24
Remedy’s CEO was interviewed by Dring. 00:00 Introduction 03:12 Controversial appointment 06:44 Scale Remedy 08:55 Self-publishing 12:06 Asia 14:54 Not Remedy 18:16 Commercial hits 20:37 FBC: Firebreak 23:27 Control Resonant 26:35 Annapurna partnership 29:38 AI 31:58 Remedy opportunity...
yesterday
by Trivial
21
It seems the rest of the internet has also woken up to connect Take-Two’s earnings call M&A talk to Remedy. Kotaku MSN There is also speculation on the Resetera discussion forum that Take-Two’s M&A talk potentially refers to Remedy. However, it is good to clarify that there are no...
5/24/2026, 10:47 AM
19
T2 might be the best potential buyer, but Tencent already owns 14.8% of Remedy, and additionally holds a €15M convertible loan with a conversion window starting on October 31, 2027. The conversion price is €27.20/share, with a maximum of 811,100 new shares. If that were fully converted...
5/23/2026, 7:35 AM
by Miika21
11
Take-Two’s earnings report also touched upon upcoming Remakes and Remastered versions. Muropaketti.com – 24 May 26 Take-Twolta on tulossa useita remakeja ja remasterointia - Muropaketti.com Take-Two paljasti tulevien vuosien remake- ja remaster-suunnitelmistaan tuoreessa tulosraportissaan...
5/24/2026, 11:06 AM
by Henkka
7
Perhaps we are talking about different things. I interpret that you mean trading activity, whereas I am talking about active/activist ownership. Tencent is a massive company and likely decides on a case-by-case basis whether to act actively or passively in its holdings, and whether...
5/23/2026, 4:52 PM
7
Read more on our forum

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.